Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Vicor Corporation Common Stock (VICR) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade
Vicor Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Dr. Reddy's Laboratories Ltd Common Stock vs Vicor Corporation Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Vicor Corporation Common Stock trades at $238.97 (market cap $12.30B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock and Vicor Corporation Common Stock are close in size by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Vicor Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Vicor Corporation Common Stock for 0 Days on average.

RDYVICR
Market Cap
$10.78B$12.30B
Volume
2,724,3431,052,269
Sector
HealthTechnology
52-Week High
$15.38$379.78
52-Week Low
$11.38$57.31
Typical Hold Time
0 Days0 Days
Enterprise Value
$10.68B$11.86B
Dividend Yield
0.65%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDY
100% Buy0% Sell
Avg holding period · 0 Days
VICR
100% Buy0% Sell
Avg holding period · 0 Days

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →

About Vicor Corporation Common Stock

Vicor Corporation designs, manufactures, and markets modular power components and complete power systems, serving high-performance computing, data center, industrial, automotive, and aerospace and defense markets.

Read more on VICR →